Attitudes toward Cognitive Enhancers The discourse surrounding cognitive enhancers (CEs), often referred to colloquially as “smart drugs,” represents a critical intersection of pharmacology, ethics, and societal values. Cognitive enhancers are defined primarily as pharmacological agents used by healthy individuals to improve executive functions such as memory, attention, planning, and working speed, often without a diagnosed […]
Introduction to Cognitive Enhancement and Methylphenidate The increasing demand for pharmacological agents that enhance cognitive function among healthy individuals presents a significant challenge to contemporary medical ethics and professional practice. Cognitive enhancement (CE) refers broadly to the use of drugs, technologies, or other interventions to improve mental faculties such as memory, focus, attention, and executive […]
Introduction to Pharmacological Cognitive Enhancement (PCE) Pharmacological Cognitive Enhancement (PCE), often involving the use of prescription drugs like stimulants (e.g., modafinil, methylphenidate) or memory-enhancing agents by healthy individuals, represents a profound intersection of medicine, ethics, and societal ambition. Attitudes toward PCE are highly complex, reflecting deep-seated values regarding performance, natural limits, and the purpose of […]